Cor Vasa 2022, 64(Suppl. 4):96-102

The year in cardiovascular medicine 2021: arrhythmias

Harry J.G.M. Crijns1,*, Prashantan Sanders2, Christine M. Albert3, Pier D. Lambiase4
1 Department of Cardiology and Cardiovascular Research Centre Maastricht (CARIM), Maastricht University Medical Centre
2 Centre for Heart Rhythm Disorders, University of Adelaide and Royal Adelaide Hospital
3 Department of Cardiology, Smidt Heart Institute, Cedars Sinai Medical Center (CMA)
4 Department of Cardiology, University College London and Barts Heart Centre

Received Date: 09 December 2021; Revision received Date: 22 December 2021; Accepted Date: 06 January 2022; Publication
date (electronic): 08 January 2022
Reproduced from: Crijns HJGM, Sanders P, Albert CM, Lambiase PD. The year in cardiovascular medicine 2021: arrhythmias. Eur Heart J 2022;43:1191–1197, https://doi.org/10.1093/eurheartj/ehac007, by permission of Oxford University Press on behalf of the European Society of Cardiology

Keywords: Guidelines; Randomized trial; Public health; Societal impact; Atrial fi brillation; Ventricular arrhythmias; Brugada syndrome; Implantable defi brillator; Cardiogenetics

Received: December 21, 2022; Accepted: December 21, 2022; Published: December 30, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Crijns HJGM, Sanders P, Albert CM, Lambiase PD. The year in cardiovascular medicine 2021: arrhythmias. Cor Vasa. 2022;64(Suppl. 4):96-102.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Albert CM, Cook NR, Pester J, Moorthy MV, Ridge C, Danik JS, et al. Effect of marine omega-3 fatty acid and vitamin D supplementation on incident atrial fibrillation: a randomized clinical trial. JAMA 2021;325:1061-1073. Go to original source... Go to PubMed...
    2. Gencer B, Djousse L, Al-Ramady OT, Cook NR, Manson JE, Albert CM. Effect of long-term marine omega-3 fatty acids supplementation on the risk of atrial fibrillation in randomized controlled trials of cardiovascular outcomes: a systematic review and meta-analysis. Circulation 2021;144:1981-1990. Go to original source... Go to PubMed...
    3. Csengeri D, Sprünker NA, Di Castelnuovo A, Niiranen T, Vishram-Nielsen JK, Costanzo S, et al. Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes. Eur Heart J 2021;42:1170-1177. Go to original source... Go to PubMed...
    4. Wong JA, Conen D. Alcohol consumption, atrial fibrillation, and cardiovascular disease: finding the right balance. Eur Heart J 2021;42:1178-1179. Go to original source... Go to PubMed...
    5. Lee SR, Choi EK, Jung JH, Han KD, Oh S, Lip GYH. Lower risk of stroke after alcohol abstinence in patients with incident atrial fibrillation: a nationwide population-based cohort study. Eur Heart J 2021;42:4759-4768. Go to original source... Go to PubMed...
    6. Takahashi Y, Nitta J, Kobori A, Sakamoto Y, Nagata Y, Tanimoto K, et al. Alcohol consumption reduction and clinical outcomes of catheter ablation for atrial fibrillation. Circ Arrhythm Electrophysiol 2021;14:e009770. Go to original source... Go to PubMed...
    7. Tu SJ, Gallagher C, Elliott AD, Linz D, Pitman BM, Hendriks JML, et al. Risk thresholds for total and beverage-specific alcohol consumption and incident atrial fibrillation. JACC Clin Electrophysiol 2021;7:1561-1569. Go to original source... Go to PubMed...
    8. Wang N, Sun Y, Zhang H, Wang B, Chen C, Wang Y, et al. Long-term night shift work is associated with the risk of atrial fibrillation and coronary heart disease. Eur Heart J 2021;42:4180-4188. Go to original source... Go to PubMed...
    9. Wei D, Olofsson T, Chen H, Janszky I, Fang F, Ljung R, et al. Death of a child and the risk of atrial fibrillation: a nationwide cohort study in Sweden. Eur Heart J 2021;42:1489-1495. Go to original source... Go to PubMed...
    10. Smolderen KG, Burg MM. A broken heart after child loss. Eur Heart J 2021;42:1496-1498. Go to original source... Go to PubMed...
    11. Shahrbabaki SS, Linz D, Hartmann S, Redline S, Baumert M. Sleep arousal burden is associated with long-term all-cause and cardiovascular mortality in 8001 community-dwelling older men and women. Eur Heart J 2021;42:2088-2099. Go to original source... Go to PubMed...
    12. Agerström J, Carlsson M, Bremer A, Herlitz J, Israelsson J, Årestedt K. Discriminatory cardiac arrest care? Patients with low socioeconomic status receive delayed cardiopulmonary resuscitation and are less likely to survive an in-hospital cardiac arrest. Eur Heart J 2021;42:861-869. Go to original source... Go to PubMed...
    13. Sondergaard KB, Wissenberg M, Gerds TA, Rajan S, Karlsson L, Kragholm K, et al. Bystander cardiopulmonary resuscitation and long-term outcomes in out-of-hospital cardiac arrest according to location of arrest. Eur Heart J 2019;40:309-318. Go to original source... Go to PubMed...
    14. Jayawardana S, Mossialos E. The cost of prejudice for poorer people: understanding experiences of discrimination in cardiac arrest care. Eur Heart J 2021;42:870-872. Go to original source... Go to PubMed...
    15. Marijon E, Karam N, Jouven X. Cardiac arrest occurrence during successive waves of the COVID-19 pandemic: direct and indirect consequences. Eur Heart J 2021;42:1107-1109. Go to original source... Go to PubMed...
    16. O'Shea CJ, Thomas G, Middeldorp ME, Harper C, Elliott AD, Ray N, et al. Ventricular arrhythmia burden during the coronavirus disease 2019 (COVID-19) pandemic. Eur Heart J 2021;42:520-528. Go to original source... Go to PubMed...
    17. O'Shea CJ, Middeldorp ME, Thomas G, Harper C, Elliott AD, Ray N, et al. Atrial fibrillation burden during the coronavirus disease 2019 pandemic. Europace 2021;23:1493-1501. Go to original source... Go to PubMed...
    18. Stieglis R, Zijlstra JA, Riedijk F, Smeekes M, van der Worp WE, Tijssen JGP, et al. Alert system-supported lay defibrillation and basic life-support for cardiac arrest at home. Eur Heart J 2021. Go to original source... Go to PubMed...
    19. Schierbeck S, Hollenberg J, Nord A, Svensson L, Nordberg P, Ringh M, et al. Automated external defibrillators delivered by drones to patients with suspected out-of-hospital cardiac arrest. Eur Heart J 2021. Go to original source...
    20. Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J 2021;42:3427-3520. Go to original source... Go to PubMed...
    21. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstrom-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 2021;42:373-498. Go to original source... Go to PubMed...
    22. Svendsen JH, Diederichsen SZ, Hojberg S, Krieger DW, Graff C, Kronborg C, et al. Implantable loop recorder detection of atrial fibrillation to prevent stroke (the LOOP study): a randomised controlled trial. Lancet 2021;398:1507-1516. Go to original source... Go to PubMed...
    23. Svennberg E, Friberg L, Frykman V, Al-Khalili F, Engdahl J, Rosenqvist M. Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial. Lancet 2021;398:1498-1506. Go to original source... Go to PubMed...
    24. Bonnesen MP, Frodi DM, Haugan KJ, Kronborg C, Graff C, Hojberg S, et al. Day-to-day measurement of physical activity and risk of atrial fibrillation. Eur Heart J 2021;42:3979-3988. Go to original source... Go to PubMed...
    25. Khurshid S, Weng LC, Al-Alusi MA, Halford JL, Haimovich JS, Benjamin EJ, et al. Accelerometer-derived physical activity and risk of atrial fibrillation. Eur Heart J 2021;42:2472-2483. Go to original source... Go to PubMed...
    26. Elliott AD, Middeldorp ME, Linz DK. The ins and outs of physical activity monitoring: implications for atrial fibrillation management. Eur Heart J 2021;42:3989-3991. Go to original source... Go to PubMed...
    27. Kotecha D, Bunting KV, Gill SK, Mehta S, Stanbury M, Jones JC, et al. Effect of digoxin vs bisoprolol for heart rate control in atrial fibrillation on patient-reported quality of life: the RATE-AF randomized clinical trial. JAMA 2020;324:2497-2508. Go to original source... Go to PubMed...
    28. Hallberg P, Lindbäck J, Lindahl B, Stenestrand U. Digoxin and mortality in atrial fibrillation: a prospective cohort study. Eur J Clin Pharmacol 2007;63:959-971. Go to original source... Go to PubMed...
    29. Turakhia MP, Santangeli P, Winkelmayer WC, Xu X, Ullal AJ, Than CT, et al. Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study. J Am Coll Cardiol 2014;64:660-668. Go to original source... Go to PubMed...
    30. Whitbeck MG, Charnigo RJ, Khairy P, Ziada K, Bailey AL, Zegarra MM, et al. Increased mortality among patients taking digoxin-analysis from the AFFIRM study. Eur Heart J 2013;34:1481-1488. Go to original source... Go to PubMed...
    31. Lim KT, Davis MJ, Powell A, Arnolda L, Moulden K, Bulsara M, et al. Ablate and pace strategy for atrial fibrillation: long-term outcome of AIRCRAFT trial. Europace 2007;9:498-505. Go to original source... Go to PubMed...
    32. Wood MA, Brown-Mahoney C, Kay GN, Ellenbogen KA. Clinical outcomes after ablation and pacing therapy for atrial fibrillation: a meta-analysis. Circulation 2000;101:1138-1144. Go to original source... Go to PubMed...
    33. Brignole M, Pentimalli F, Palmisano P, Landolina M, Quartieri F, Occhetta E, et al. AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial. Eur Heart J 2021;42:4731-4739. Go to original source... Go to PubMed...
    34. Sutton R, Fedorowski A, Olshansky B, Gert van Dijk J, Abe H, Brignole M, et al. Tilt testing remains a valuable asset. Eur Heart J 2021;42:1654-1660. Go to original source... Go to PubMed...
    35. Brignole M, Russo V, Arabia F, Oliveira M, Pedrote A, Aerts A, et al. Cardiac pacing in severe recurrent reflex syncope and tilt-induced asystole. Eur Heart J 2021;42:508-516. Go to original source... Go to PubMed...
    36. Simons SO, Elliott A, Sastry M, Hendriks JM, Arzt M, Rienstra M, et al. Chronic obstructive pulmonary disease and atrial fibrillation: an interdisciplinary perspective. Eur Heart J 2021;42:532-540. Go to original source... Go to PubMed...
    37. Romiti GF, Corica B, Pipitone E, Vitolo M, Raparelli V, Basili S, et al. Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients. Eur Heart J 2021;42:3541-3554. Go to original source... Go to PubMed...
    38. Verdonschot JAJ, Merlo M, Dominguez F, Wang P, Henkens M, Adriaens ME, et al. Phenotypic clustering of dilated cardiomyopathy patients highlights important pathophysiological differences. Eur Heart J 2021;42:162-174. Go to original source... Go to PubMed...
    39. Park S, Lee S, Kim Y, Lee Y, Kang MW, Kim K, et al. Atrial fibrillation and kidney function: a bidirectional Mendelian randomization study. Eur Heart J 2021;42:2816-2823. Go to original source... Go to PubMed...
    40. Benn M. Atrial fibrillation and chronic kidney disease. Eur Heart J 2021;42:2824-2826. Go to original source... Go to PubMed...
    41. Whitlock RP, Belley-Cote EP, Paparella D, Healey JS, Brady K, Sharma M, et al. Left atrial appendage occlusion during cardiac surgery to prevent stroke. N Engl J Med 2021;384:2081-2091. Go to original source... Go to PubMed...
    42. Verma S, Bhatt DL, Tseng EE. Time to remove the left atrial appendage at surgery: LAAOS III in perspective. Circulation 2021;144:1088-1090. Go to original source... Go to PubMed...
    43. Toorop MMA, Chen Q, Tichelaar V, Cannegieter SC, Lijfering WM. Predictors, time course, and outcomes of persistence patterns in oral anticoagulation for non-valvular atrial fibrillation: a Dutch Nationwide Cohort Study. Eur Heart J 2021;42:4126-4137. Go to original source... Go to PubMed...
    44. Oyama K, Giugliano RP, Berg DD, Ruff CT, Jarolim P, Tang M, et al. Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial. Eur Heart J 2021;42:1698-1706. Go to original source... Go to PubMed...
    45. Krohn-Grimberghe M, Duerschmied D, Bode C. What do we learn by repeating the ABC? Eur Heart J 2021;42:1707-1709. Go to original source... Go to PubMed...
    46. Sulzgruber P, Doehner W, Niessner A. Personalized anti-thrombotic management of patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1-a statement of the ESC Working Group on Cardiovascular Pharmacotherapy and ESC Council on Stroke [corrected]. Eur Heart J 2021;42:541-543. Go to original source... Go to PubMed...
    47. Rosso R, Hochstadt A, Viskin D, Chorin E, Schwartz AL, Tovia-Brodie O, et al. Polymorphic ventricular tachycardia, ischaemic ventricular fibrillation, and torsade de pointes: importance of the QT and the coupling interval in the differential diagnosis. Eur Heart J 2021;42:3965-3975. Go to original source... Go to PubMed...
    48. van der Werf C, Lambiase PD. Initiation and management of polymorphic ventricular tachycardia: history gone full circle. Eur Heart J 2021;42:3976-3978. Go to original source... Go to PubMed...
    49. Steinberg C, Davies B, Mellor G, Tadros R, Laksman ZW, Roberts JD, et al. Short-coupled ventricular fibrillation represents a distinct phenotype among latent causes of unexplained cardiac arrest: a report from the CASPER registry. Eur Heart J 2021;42:2827-2838. Go to original source... Go to PubMed...
    50. Younis A, Goldberger JJ, Kutyifa V, Zareba W, Polonsky B, Klein H, et al. Predicted benefit of an implantable cardioverter-defibrillator: the MADIT-ICD benefit score. Eur Heart J 2021;42:1676-1684. Go to original source... Go to PubMed...
    51. Probst V, Goronflot T, Anys S, Tixier R, Briand J, Berthome P, et al. Robustness and relevance of predictive score in sudden cardiac death for patients with Brugada syndrome. Eur Heart J 2021;42:1687-1695. Go to original source... Go to PubMed...
    52. Delise P. Risk stratification in Brugada syndrome: the challenge of the grey zone. Eur Heart J 2021;42:1696-1697. Go to original source... Go to PubMed...
    53. Ishikawa T, Kimoto H, Mishima H, Yamagata K, Ogata S, Aizawa Y, et al. Functionally validated SCN5A variants allow interpretation of pathogenicity and prediction of lethal events in Brugada syndrome. Eur Heart J 2021;42:2854-2863. Go to original source... Go to PubMed...
    54. Ciconte G, Monasky MM, Santinelli V, Micaglio E, Vicedomini G, Anastasia L, et al. Brugada syndrome genetics is associated with phenotype severity. Eur Heart J 2021;42:1082-1090. Go to original source... Go to PubMed...
    55. Postema PG, Walsh R, Bezzina CR. Illuminating the path from genetics to clinical outcome in Brugada syndrome. Eur Heart J 2021;42:1091-1093. Go to original source... Go to PubMed...
    56. Nauffal V, Marstrand P, Han L, Parikh VN, Helms AS, Ingles J, et al. Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy. Eur Heart J 2021;42:3932-3944. Go to original source... Go to PubMed...
    57. Willems S, Borof K, Brandes A, Breithardt G, Camm AJ, Crijns H, et al. Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial. Eur Heart J 2021. Go to original source... Go to PubMed...

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes